Approximately 2,350 display cases of IVERHART MAX (ivermectin/pyrantel pamoate/praziquantel) chewable tablets for dogs weighing 50.1 to 100 lbs. have been recalled. Testing conducted nine months after manufacture showed that the product's stability had failed, meaning the active ingredients were lower than required levels. Because this medication is used to prevent heartworms and treat various parasites, a lower potency could result in the product being less effective than intended. These tablets were sold in 6-tablet boxes through veterinary clinics and pharmacies across several states.
The medication's potency dropped below acceptable levels during its shelf life, which may lead to inadequate protection against heartworms, hookworms, roundworms, or tapeworms. If a pet does not receive the full intended dose of active ingredients, they remain at risk for parasitic infections that the drug is designed to prevent or treat.
Contact your veterinarian or pharmacist for guidance. Return any unused product to the pharmacy for a refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response